[Conditional reimbursement: a tool to reduce uncertainty relating the value of medicines and reinforce their continuous evaluation in real-life].
In order to alleviate the inherent uncertainty that comes with the market access and public funding of new health products, a conditional reimbursement mechanism is proposed. The latter is circumscribed by recommendations regarding its implementation in limited cases in order to allow for a fair access of patients to therapeutic innovations, within economic conditions both optimum and reviewable.